AstraZeneca PLC (AZN)
71.20
+0.35
(+0.49%)
USD |
NASDAQ |
Apr 24, 16:00
72.88
+1.68
(+2.36%)
After-Hours: 20:00
AstraZeneca Cash and Short Term Investments (Quarterly): 5.86B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.86B |
September 30, 2023 | 5.115B |
June 30, 2023 | 5.812B |
March 31, 2023 | 6.462B |
December 31, 2022 | 6.243B |
September 30, 2022 | 4.898B |
June 30, 2022 | 4.887B |
March 31, 2022 | 5.823B |
December 31, 2021 | 6.398B |
September 30, 2021 | 7.149B |
June 30, 2021 | 15.63B |
March 31, 2021 | 7.765B |
December 31, 2020 | 7.992B |
September 30, 2020 | 8.446B |
June 30, 2020 | 6.115B |
March 31, 2020 | 4.165B |
December 31, 2019 | 6.217B |
September 30, 2019 | 4.78B |
June 30, 2019 | 6.247B |
March 31, 2019 | 4.958B |
December 31, 2018 | 5.594B |
September 30, 2018 | 4.228B |
June 30, 2018 | 3.777B |
March 31, 2018 | 3.871B |
December 31, 2017 | 4.554B |
Date | Value |
---|---|
September 30, 2017 | 5.211B |
June 30, 2017 | 6.237B |
March 31, 2017 | 3.659B |
December 31, 2016 | 5.811B |
September 30, 2016 | 3.999B |
June 30, 2016 | 4.646B |
March 31, 2016 | 4.099B |
December 31, 2015 | 6.743B |
September 30, 2015 | 4.577B |
June 30, 2015 | 4.498B |
March 31, 2015 | 3.685B |
December 31, 2014 | 7.041B |
September 30, 2014 | 5.95B |
June 30, 2014 | 5.777B |
March 31, 2014 | 5.156B |
December 31, 2013 | 9.894B |
September 30, 2013 | 8.317B |
June 30, 2013 | 9.091B |
March 31, 2013 | 8.029B |
December 31, 2012 | 8.223B |
September 30, 2012 | 6.816B |
June 30, 2012 | 9.196B |
March 31, 2012 | 9.969B |
December 31, 2011 | 11.28B |
September 30, 2011 | 10.78B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.165B
Minimum
Mar 2020
15.63B
Maximum
Jun 2021
6.632B
Average
6.217B
Median
Dec 2019
Cash and Short Term Investments (Quarterly) Benchmarks
GSK PLC | 6.359B |
Amgen Inc | 10.94B |
Sanofi SA | 9.926B |
Viking Therapeutics Inc | 362.08M |
Fusion Pharmaceuticals Inc | 233.61M |